tiprankstipranks
Cannabis Bioscience International Holdings (CBIH)
OTHER OTC:CBIH
US Market
CBIH
Cannabis Bioscience International Holdings
RESEARCH TOOLSreports

Cannabis Bioscience International Holdings (CBIH) Ratios

44 Followers

Cannabis Bioscience International Holdings Ratios

CBIH's free cash flow for Q3 2025 was $-3.64. For the 2025 fiscal year, CBIH's free cash flow was decreased by $ and operating cash flow was $-8.32. See a summary of the company’s cash flow.
Ratios
TTM
May 25May 24May 23May 22
Liquidity Ratios
Current Ratio
 <0.01 0.03 0.02 0.05 0.22
Quick Ratio
 <0.01 0.03 0.02 0.05 0.22
Cash Ratio
 <0.01 0.01 <0.01 0.02 0.14
Solvency Ratio
 -0.35 -0.43 -0.58 -1.57 -1.88
Operating Cash Flow Ratio
 -0.20 -0.35 -0.54 -2.37 -3.83
Short-Term Operating Cash Flow Coverage
 -1.56 -1.99 -2.98 -6.71 -6.14
Net Current Asset Value
$ -1.47M$ -1.17M$ -1.11M$ -615.59K$ -421.35K
Leverage Ratios
Debt-to-Assets Ratio
 263.04 13.18 7.64 8.99 3.52
Debt-to-Equity Ratio
 -0.28 -0.36 -0.40 -0.66 -1.07
Debt-to-Capital Ratio
 -0.38 -0.57 -0.68 -1.93 14.97
Long-Term Debt-to-Capital Ratio
 -0.20 -0.27 -0.30 -0.73 -2.08
Financial Leverage Ratio
 >-0.01 -0.03 -0.05 -0.07 -0.30
Debt Service Coverage Ratio
 -0.84 -0.97 -1.53 -3.83 -4.38
Interest Coverage Ratio
 -1.90 -2.34 -2.94 -10.81 -17.40
Debt to Market Cap
 0.35 64.59 66.24 96.18 118.38
Interest Debt Per Share
 <0.01 0.06 0.06 0.05 0.05
Net Debt to EBITDA
 -1.34 -1.21 -0.88 -0.42 -0.43
Profitability Margins
Gross Profit Margin
-0.06%86.76%81.68%70.50%78.25%
EBIT Margin
-252.26%-121.58%-195.36%-297.20%-388.01%
EBITDA Margin
-245.55%-110.73%-199.78%-285.72%-388.01%
Operating Profit Margin
-312.80%-139.05%-195.36%-310.38%-413.09%
Pretax Profit Margin
-416.97%-181.12%-261.75%-337.40%-411.75%
Net Profit Margin
-416.81%-181.12%-261.75%-325.91%-411.75%
Continuous Operations Profit Margin
-416.97%-181.12%-261.75%-325.91%-411.75%
Net Income Per EBT
99.96%100.00%100.00%96.60%100.00%
EBT Per EBIT
133.30%130.25%133.98%108.70%99.67%
Return on Assets (ROA)
-33373.58%-1721.52%-1139.47%-2380.20%-805.48%
Return on Equity (ROE)
39.33%47.17%60.36%174.52%245.17%
Return on Capital Employed (ROCE)
31.76%46.10%58.94%287.40%782.37%
Return on Invested Capital (ROIC)
36.45%56.68%75.71%470.88%-3435.97%
Return on Tangible Assets
-33373.58%-1721.52%-1139.47%-2380.20%-805.48%
Earnings Yield
-44.32%-8535.55%-10521.57%-25763.24%-27352.17%
Efficiency Ratios
Receivables Turnover
 97.65 19.51 12.36 30.03 12.21
Payables Turnover
 0.65 0.40 0.23 0.84 0.69
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 108.42 6.98 13.25 3.57
Asset Turnover
 80.07 9.51 4.35 7.30 1.96
Working Capital Turnover Ratio
 -0.11 -0.34 -0.41 -1.17 -1.40
Cash Conversion Cycle
 -558.24 -894.50 -1.54K -422.56 -502.49
Days of Sales Outstanding
 3.74 18.71 29.54 12.15 29.91
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 561.98 913.21 1.57K 434.72 532.40
Operating Cycle
 3.74 18.71 29.54 12.15 29.91
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -0.03 -0.05 -0.09 -0.11
Free Cash Flow Per Share
 >-0.01 -0.03 -0.05 -0.09 -0.11
CapEx Per Share
 <0.01 <0.01 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -49.05K -82.41K 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -49.05K -82.41K 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -0.60 -0.78 -1.10 -2.34 -2.21
Operating Cash Flow to Sales Ratio
 -1.97 -1.09 -1.93 -2.88 -3.98
Free Cash Flow Yield
-20.97%-5126.54%-7743.75%-22783.71%-26441.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 >-0.01 -0.01 >-0.01 >-0.01 >-0.01
Price-to-Sales (P/S) Ratio
 9.40 0.02 0.02 0.01 0.02
Price-to-Book (P/B) Ratio
 -0.79 >-0.01 >-0.01 >-0.01 >-0.01
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.77 -0.02 -0.01 >-0.01 >-0.01
Price-to-Operating Cash Flow Ratio
 -4.77 -0.02 -0.01 >-0.01 >-0.01
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 <0.01 <0.01 >-0.01
Price-to-Fair Value
 -0.79 >-0.01 >-0.01 >-0.01 >-0.01
Enterprise Value Multiple
 -5.17 -1.23 -0.89 -0.43 -0.43
Enterprise Value
 1.57M 413.71K 442.31K 385.03K 358.15K
EV to EBITDA
 -5.17 -1.23 -0.89 -0.43 -0.43
EV to Sales
 12.69 1.37 1.78 1.22 1.67
EV to Free Cash Flow
 -6.44 -1.26 -0.92 -0.42 -0.42
EV to Operating Cash Flow
 -6.44 -1.26 -0.92 -0.42 -0.42
Tangible Book Value Per Share
 >-0.01 -0.11 -0.10 -0.06 -0.04
Shareholders’ Equity Per Share
 >-0.01 -0.11 -0.10 -0.06 -0.04
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.03 0.00
Revenue Per Share
 <0.01 0.03 0.02 0.03 0.03
Net Income Per Share
 >-0.01 -0.05 -0.06 -0.10 -0.11
Tax Burden
 1.00 1.00 1.00 0.97 1.00
Interest Burden
 1.65 1.49 1.34 1.14 1.06
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 2.44 1.38 2.61 3.64 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.04 0.00
Income Quality
 0.47 0.60 0.74 0.88 0.97
Currency in USD